PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 70 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,301,460 | -14.6% | 1,068,434 | +24.4% | 0.00% | – |
| Q2 2023 | $3,866,046 | +60.3% | 859,121 | +103.1% | 0.00% | – |
| Q1 2023 | $2,411,260 | +1.4% | 423,028 | +7.5% | 0.00% | – |
| Q4 2022 | $2,377,060 | -21.7% | 393,553 | -14.3% | 0.00% | – |
| Q3 2022 | $3,034,000 | +9.8% | 459,134 | -13.3% | 0.00% | – |
| Q2 2022 | $2,764,000 | -61.9% | 529,435 | -49.7% | 0.00% | – |
| Q1 2022 | $7,258,000 | -35.0% | 1,051,960 | +17.3% | 0.00% | – |
| Q4 2021 | $11,161,000 | -50.8% | 896,504 | +23.5% | 0.00% | -100.0% |
| Q3 2021 | $22,686,000 | +12.7% | 725,962 | +3.3% | 0.00% | 0.0% |
| Q2 2021 | $20,124,000 | -31.9% | 702,842 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $29,539,000 | -35.2% | 681,725 | +7.0% | 0.00% | 0.0% |
| Q4 2020 | $45,587,000 | +2323.6% | 637,133 | +920.2% | 0.00% | – |
| Q3 2020 | $1,881,000 | – | 62,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |